<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>周四，Propanc Biopharma, Inc. (PPCB) 宣布其董事会已批准一项股票回购计划，授权公司回购最多 500 万美元的普通股。</p>
<p>公司预计该计划将使股东能够继续增加对其基础资产的拥有权，随着时间的推移改善每股经济效益，并传达管理层对业务长期价值的信心。</p>
<p>此外，首席执行官 James Nathanielsz 表示，该决定反映了公司对有纪律、灵活的资本配置的承诺。</p>
<p>在盘前交易时，PPCB 的交易价格为 2.87 美元，较纳斯达克上涨 114.23%。</p>
<p>如有意见和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

PPCB

<p>Propanc Biopharma 的董事会批准了一项 500 万美元的股票回购计划。该公司旨在增加股东的持股比例，并传达对长期价值的信心。首席执行官 James Nathanielsz 提到要进行有纪律的资本配置。在公告发布后，PPCB 股票在盘前交易中上涨超过 114%，达到了 2.87 美元</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Thursday, Propanc Biopharma, Inc. (PPCB) announced that its board has approved a share repurchase program, authorizing the company to repurchase up to $5.0 million of its common stock.</p>
<div class="lb-trans"><p>周四，Propanc Biopharma, Inc. (PPCB) 宣布其董事会已批准一项股票回购计划，授权公司回购最多 500 万美元的普通股。</p>
</div><p>The company expects the program to allow the shareholders to continue to increase their ownership in its underlying assets, improve per share economics over time, and signal management's confidence in the long-term value of the business.</p>
<div class="lb-trans"><p>公司预计该计划将使股东能够继续增加对其基础资产的拥有权，随着时间的推移改善每股经济效益，并传达管理层对业务长期价值的信心。</p>
</div><p>Moreover, CEO James Nathanielsz stated that the decision reflects the company's commitment to disciplined, flexible capital allocation.</p>
<div class="lb-trans"><p>此外，首席执行官 James Nathanielsz 表示，该决定反映了公司对有纪律、灵活的资本配置的承诺。</p>
</div><p>In the pre-market hours, PPCB is trading at $2.87, up 114.23 percent on the Nasdaq.</p>
<div class="lb-trans"><p>在盘前交易时，PPCB 的交易价格为 2.87 美元，较纳斯达克上涨 114.23%。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意见和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

Propanc Biopharma 董事会批准了 500 万美元的股票回购计划，该公司股价在盘前交易中上涨